UBS Remains a Buy on Canadian Natural (CNQ)
In a report released today, from UBS maintained a Buy rating on Canadian Natural, with a price target of C$70.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to UBS, Canadian Natural also received a Buy from ATB Cormark Capital Markets’s Patrick O’rourke in a report issued today. However, yesterday, Jefferies maintained a Hold rating on Canadian Natural (NYSE: CNQ).
Based on Canadian Natural’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of C$9.52 billion and a net profit of C$600 million. In comparison, last year the company earned a revenue of C$10.4 billion and had a net profit of C$2.27 billion
Based on the recent corporate insider activity of 157 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CNQ in relation to earlier this year.
Read More on CNQ:
Disclaimer & DisclosureReport an Issue
- Canadian Natural price target raised to C$64 from C$51 at TD Securities
- Canadian Natural price target raised to C$65 from C$61 at RBC Capital
- Canadian Natural price target raised to C$62 from C$58 at Scotiabank
- Canadian Natural price target raised to C$70 from C$56 at BMO Capital
- Canadian Natural Resources: Accelerating Cash Returns and Debt Reduction Underpin Buy Rating Despite Conservative Price Outlook
